Patents

Description

COMPUŞI CHINOLINICI ŞI CHINOXALINICI, CA INHIBITORI AI PDGF-R ŞI/SAU LCK TIROZIN KINAZEI

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO121210

Date: 30.01.2007

Inventor(s):

SPADA ALFRED P [US]

HE WEI [US]

MYERS MICHAEL R [FR]

Applicant(s):
RHONE POULENC RORER PHARMA [US]
Classification:
International patent classification (IPC):
A61F2/06; A61K31/47; A61K31/495; A61K31/498; A61K31/50; A61K31/5377; A61M29/00; A61P1/18; A61P11/00; A61P13/12; A61P17/06; A61P19/00; A61P19/08; A61P29/00; A61P35/00; A61P35/02; A61P43/00; A61P9/00; A61P9/10; C07D215/14; C07D215/20; C07D215/22; C07D215/38; C07D241/42; C07D241/44; C07D241/52; C07D241/54; C07D403/04; C07D405/10; C07D405/12; C07D453/06; C07D215/12; C07D413/00; C07D
Cooperative patent classification (CPC):
A61P1/00 (EP); A61P1/18 (EP); A61P11/00 (EP); A61P13/00 (EP); A61P13/12 (EP); A61P17/00 (EP); A61P17/06 (EP); A61P19/00 (EP); A61P19/08 (EP); A61P29/00 (EP); A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP); A61P9/00 (EP); A61P9/10 (EP); C07D215/20 (EP, KR, US); C07D215/38 (EP, KR, US); C07D241/42 (EP, KR, US); C07D241/44 (EP, KR, US); C07D241/52 (EP, KR, US); C07D241/54 (EP, KR, US); C07D403/04 (EP, KR, US); C07D405/12 (EP, KR, US); C07D453/06 (EP, KR, US)
Application info:
No.: RO19200100555
Date: 23.11.1999
Priority number(s):
US19980198720 24.11.1998 ; WO1999US27760 23.11.1999
Related patents:
AU2028400; AU768625; BG105623; BG65482; BR9915650; CA2352583; CN100357276; CN1356991; CZ20012274; EA007290; EA200100576; EE200100278; EP1133481; HU0104752; ID30406; IL143404; JP2002530387; KR100784289; KR20010086049; NO20012583; NO319803; NZ512094; NZ542336; PL348605; SK9052001; UA59480; US2001023250; US6245760; US6482834; WO0031049
Description:

Invenţia se referă la compuşi chinolinici/chinoxalinici cu formula I, care inhibă activitatea factorului de creştere a derivatelor de trombocitesau a p56lck tirozin kinazei, la compoziţii farmaceutice care conţin aceşti compuşi şi la folosirea acestor compuşi pentru tratarea unui pacient care suferă de sau este supus la o tulburare/condiţie care implică diferenţiere, proliferare celulară, producere de matrici extracelulare sau eliberare de mediator şi/sau activare sau proliferare de celule T.

cover
Share this on:
Facebook Twitter/X LinkedIn Whatsapp Email